DE69329067T2 - Pyridmidin-derivate - Google Patents
Pyridmidin-derivateInfo
- Publication number
- DE69329067T2 DE69329067T2 DE69329067T DE69329067T DE69329067T2 DE 69329067 T2 DE69329067 T2 DE 69329067T2 DE 69329067 T DE69329067 T DE 69329067T DE 69329067 T DE69329067 T DE 69329067T DE 69329067 T2 DE69329067 T2 DE 69329067T2
- Authority
- DE
- Germany
- Prior art keywords
- alkoxy
- alkyl
- halogen
- represent
- double bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26635392 | 1992-10-05 | ||
| PCT/JP1993/001412 WO1994007890A1 (en) | 1992-10-05 | 1993-10-01 | Pyrimidine compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69329067D1 DE69329067D1 (de) | 2000-08-24 |
| DE69329067T2 true DE69329067T2 (de) | 2001-05-10 |
Family
ID=17429767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69329067T Expired - Fee Related DE69329067T2 (de) | 1992-10-05 | 1993-10-01 | Pyridmidin-derivate |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5610303A (de) |
| EP (1) | EP0664291B1 (de) |
| JP (1) | JP2932693B2 (de) |
| KR (1) | KR100262254B1 (de) |
| CN (1) | CN1040322C (de) |
| AT (1) | ATE194837T1 (de) |
| AU (1) | AU672034B2 (de) |
| CA (1) | CA2146333A1 (de) |
| DE (1) | DE69329067T2 (de) |
| DK (1) | DK0664291T3 (de) |
| ES (1) | ES2149213T3 (de) |
| PT (1) | PT664291E (de) |
| WO (1) | WO1994007890A1 (de) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE171446T1 (de) * | 1993-05-26 | 1998-10-15 | Syntex Inc | 1-phenylalkanone als 5-ht4 rezeptor ligande |
| US6251938B1 (en) | 1996-12-18 | 2001-06-26 | Teva Pharmaceutical Industries, Ltd., | Phenylethylamine derivatives |
| EP1535902B1 (de) | 1996-12-18 | 2007-11-07 | Teva Pharmaceutical Industries, Ltd. | Aminoindanderivate |
| WO2000012485A1 (en) * | 1998-08-29 | 2000-03-09 | Astrazeneca Ab | Pyrimidine compounds |
| US6632820B1 (en) | 1998-08-29 | 2003-10-14 | Astrazeneca Ab | Pyrimidine compounds |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
| GB9907658D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Chemical compounds |
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004887D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004888D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0007371D0 (en) | 2000-03-28 | 2000-05-17 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0016877D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
| GB0021726D0 (en) * | 2000-09-05 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| US6359046B1 (en) | 2000-09-08 | 2002-03-19 | Crompton Corporation | Hydrocarbon core polysulfide silane coupling agents for filled elastomer compositions |
| US6635700B2 (en) | 2000-12-15 | 2003-10-21 | Crompton Corporation | Mineral-filled elastomer compositions |
| GB0103926D0 (en) * | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| GB0113041D0 (en) | 2001-05-30 | 2001-07-18 | Astrazeneca Ab | Chemical compounds |
| US7442697B2 (en) * | 2002-03-09 | 2008-10-28 | Astrazeneca Ab | 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity |
| GB0205688D0 (en) * | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| GB0205690D0 (en) * | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| GB0205693D0 (en) * | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| GB0311276D0 (en) * | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| GB0311274D0 (en) * | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| TW200528101A (en) * | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
| WO2006064251A1 (en) * | 2004-12-17 | 2006-06-22 | Astrazeneca Ab | 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| MX2008001428A (es) * | 2005-07-30 | 2008-04-04 | Astrazeneca Ab | Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos. |
| WO2007036732A1 (en) * | 2005-09-30 | 2007-04-05 | Astrazeneca Ab | Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| JP2009518433A (ja) | 2005-12-09 | 2009-05-07 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム | 神経保護用の低用量ラドスチギルの使用 |
| TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
| TW200811169A (en) * | 2006-05-26 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
| US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| US8003651B2 (en) * | 2006-07-06 | 2011-08-23 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| SI2054418T1 (sl) | 2006-07-06 | 2012-02-29 | Array Biopharma Inc | Dihidrotieno pirimidini kot AKT protein kinazni inhibitorji |
| EP2049546B1 (de) | 2006-07-06 | 2010-12-29 | Array Biopharma, Inc. | Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| US7737202B2 (en) | 2006-12-28 | 2010-06-15 | Momentive Performance Materials Inc. | Free-flowing filler composition and rubber composition containing same |
| US8592506B2 (en) | 2006-12-28 | 2013-11-26 | Continental Ag | Tire compositions and components containing blocked mercaptosilane coupling agent |
| US7968634B2 (en) | 2006-12-28 | 2011-06-28 | Continental Ag | Tire compositions and components containing silated core polysulfides |
| US7968635B2 (en) | 2006-12-28 | 2011-06-28 | Continental Ag | Tire compositions and components containing free-flowing filler compositions |
| US7781606B2 (en) | 2006-12-28 | 2010-08-24 | Momentive Performance Materials Inc. | Blocked mercaptosilane coupling agents, process for making and uses in rubber |
| US7696269B2 (en) | 2006-12-28 | 2010-04-13 | Momentive Performance Materials Inc. | Silated core polysulfides, their preparation and use in filled elastomer compositions |
| US7960460B2 (en) | 2006-12-28 | 2011-06-14 | Momentive Performance Materials, Inc. | Free-flowing filler composition and rubber composition containing same |
| US7968636B2 (en) | 2006-12-28 | 2011-06-28 | Continental Ag | Tire compositions and components containing silated cyclic core polysulfides |
| US7968633B2 (en) | 2006-12-28 | 2011-06-28 | Continental Ag | Tire compositions and components containing free-flowing filler compositions |
| US7687558B2 (en) | 2006-12-28 | 2010-03-30 | Momentive Performance Materials Inc. | Silated cyclic core polysulfides, their preparation and use in filled elastomer compositions |
| ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
| US8377937B2 (en) * | 2007-07-05 | 2013-02-19 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| NZ582692A (en) | 2007-07-05 | 2012-05-25 | Array Biopharma Inc | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| EP2240455B1 (de) * | 2008-01-09 | 2012-12-26 | Array Biopharma, Inc. | Hydroxylierte pyrimidyl-cyclopentane als akt-proteinkinasehemmer |
| RU2504542C2 (ru) * | 2008-01-09 | 2014-01-20 | Эррэй Биофарма Инк. | Гидроксилированные пиримидилциклопентаны в качестве ингибиторов протеинкиназы (акт) |
| EP2305645B1 (de) * | 2008-06-20 | 2012-05-16 | NHWA Pharma.corporation | Aralkylpiperidinderivate und ihre verwendungen als schmerz- oder beruhigungsmittel |
| EP2475428B1 (de) | 2009-09-11 | 2015-07-01 | Probiodrug AG | Heterocyclische derivate als glutaminylcyclase-hemmer |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| SG183229A1 (en) | 2010-03-10 | 2012-09-27 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| KR20140025434A (ko) | 2011-04-01 | 2014-03-04 | 제넨테크, 인크. | Akt 억제제 화합물 및 화학요법제의 조합물, 및 사용 방법 |
| EP2694073B1 (de) | 2011-04-01 | 2018-08-08 | Genentech, Inc. | Kombinationen aus akt- und mek-hemmer zur behandlung von krebs |
| EP3461819B1 (de) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Hemmer der glutaminylcyclase |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57203072A (en) * | 1981-06-05 | 1982-12-13 | Sankyo Co Ltd | 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient |
| DE3464406D1 (de) * | 1984-04-10 | 1987-07-30 | Reinhard Lipinski | Linear transporter |
| DE3514074A1 (de) * | 1985-04-18 | 1986-10-23 | Herion-Werke Kg, 7012 Fellbach | Kolbenstangenloser zylinder |
| JP2507933B2 (ja) * | 1987-04-02 | 1996-06-19 | 三菱マテリアル株式会社 | ボ−ルネジ |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JPH0819924B2 (ja) * | 1987-06-30 | 1996-03-04 | 豊和工業株式会社 | 圧流体シリンダのクッション装置 |
| JPH071041B2 (ja) * | 1988-03-26 | 1995-01-11 | 豊和工業株式会社 | ガイド付ロッドレスシリンダ |
| JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
| JPH02225807A (ja) * | 1989-02-27 | 1990-09-07 | G Liebermann Walter | スライダー |
-
1993
- 1993-10-01 WO PCT/JP1993/001412 patent/WO1994007890A1/ja active IP Right Grant
- 1993-10-01 CA CA002146333A patent/CA2146333A1/en not_active Abandoned
- 1993-10-01 AU AU48348/93A patent/AU672034B2/en not_active Ceased
- 1993-10-01 AT AT93921102T patent/ATE194837T1/de not_active IP Right Cessation
- 1993-10-01 DK DK93921102T patent/DK0664291T3/da active
- 1993-10-01 US US08/411,838 patent/US5610303A/en not_active Expired - Fee Related
- 1993-10-01 DE DE69329067T patent/DE69329067T2/de not_active Expired - Fee Related
- 1993-10-01 EP EP93921102A patent/EP0664291B1/de not_active Expired - Lifetime
- 1993-10-01 PT PT93921102T patent/PT664291E/pt unknown
- 1993-10-01 JP JP6508904A patent/JP2932693B2/ja not_active Expired - Fee Related
- 1993-10-01 ES ES93921102T patent/ES2149213T3/es not_active Expired - Lifetime
- 1993-10-01 KR KR1019950701299A patent/KR100262254B1/ko not_active IP Right Cessation
- 1993-10-05 CN CN93118642A patent/CN1040322C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100262254B1 (ko) | 2000-07-15 |
| WO1994007890A1 (en) | 1994-04-14 |
| EP0664291A4 (de) | 1995-05-23 |
| KR950703553A (ko) | 1995-09-20 |
| CN1040322C (zh) | 1998-10-21 |
| DE69329067D1 (de) | 2000-08-24 |
| EP0664291B1 (de) | 2000-07-19 |
| ATE194837T1 (de) | 2000-08-15 |
| JP2932693B2 (ja) | 1999-08-09 |
| AU672034B2 (en) | 1996-09-19 |
| PT664291E (pt) | 2000-11-30 |
| DK0664291T3 (da) | 2000-10-30 |
| EP0664291A1 (de) | 1995-07-26 |
| CA2146333A1 (en) | 1994-04-14 |
| AU4834893A (en) | 1994-04-26 |
| ES2149213T3 (es) | 2000-11-01 |
| CN1088207A (zh) | 1994-06-22 |
| US5610303A (en) | 1997-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69329067D1 (de) | Pyridmidin-derivate | |
| FI855117A (fi) | Segmenttipolyestereitä ja niiden kaltaisia yhdisteitä käytettäviksi lianirrotusaineina pesuainekoostumuksissa | |
| FI813283L (fi) | Karboxialkyldipeptider foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner | |
| CO5050332A1 (es) | Composiciones fungicidas que comprenden 2-metoxibenzofenonas | |
| IE873467L (en) | Aryloxy and arylacyloxymethyl aminomethylketones | |
| DE60220188D1 (de) | Hemmer des phosphattransports | |
| PT756594E (pt) | Preparacao de oxadiazinas artropodicidas | |
| ATE343383T1 (de) | Hemmer der zelladhäsion | |
| HU9702040D0 (en) | Atherosclerosis treatment | |
| ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| ATE234304T1 (de) | Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte | |
| ATE59842T1 (de) | Indanamin-derivate als antiarrhythmische mittel. | |
| ATE285238T1 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl- phenol derivaten | |
| DK415789D0 (da) | Tetracykliske antidepressive midler | |
| DK1049686T3 (da) | Nyttige mellemprodukter og fremgangsmåder ved semisyntese af paclitaxel og analoger deraf | |
| DE69224058T2 (de) | Benzodioxanderivate | |
| DK0401125T3 (da) | Biphenylderivater, fremgangsmåde til fremstilling af disse samt mellemprodukter derfor | |
| PL325082A1 (en) | Novel compounds of benzene sulphonylamine, method of obtaining them and pharmaceutic compositions containing such compounds | |
| FI970452A (fi) | Leukotrieenin biosynteesin estäminen ureajohdannaisten avulla | |
| DK0826663T3 (da) | Alkynylaminosyrederivater og deres anvendelse som farmaceutiske forbindelser | |
| FR2684993B1 (fr) | Procede de preparation de derives d'amino-2 nitro-4 benzothiazole et intermediaires. | |
| FR2684992B1 (fr) | Procede de preparation d'amino-2 nitro-7 benzothiazoles. | |
| IT1213440B (it) | 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de | ||
| 8370 | Indication related to discontinuation of the patent is to be deleted | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |